2016
DOI: 10.1007/s10549-016-4067-6
|View full text |Cite
|
Sign up to set email alerts
|

Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer

Abstract: PurposeAdministration of 5 million alloreactive natural killer (NK) cells after low-dose chemo-irradiation cured mice of 4T1 breast cancer, supposedly dose dependent. We now explored the efficacy of bone marrow as alternative in vivo source of NK cells for anti-breast cancer treatment, as methods for in vitro clinical scale NK cell expansion are still in developmental phases.MethodsProgression-free survival (PFS) after treatment with different doses of spleen-derived alloreactive NK cells to 4T1-bearing Balb/c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 73 publications
0
1
0
Order By: Relevance
“…Even there are some studies for estimation of the actual target organ volume by using manual measurements in three axes, to the best of our knowledge, estimation of subcutaneous xenograft tumor volume measured by 3D high resolution ultrasound based on manual caliper measurements has not been studied yet. (13,14). Injections were performed to 14 nude mice.…”
Section: Introductionmentioning
confidence: 99%
“…Even there are some studies for estimation of the actual target organ volume by using manual measurements in three axes, to the best of our knowledge, estimation of subcutaneous xenograft tumor volume measured by 3D high resolution ultrasound based on manual caliper measurements has not been studied yet. (13,14). Injections were performed to 14 nude mice.…”
Section: Introductionmentioning
confidence: 99%